Who invested in Magenta Therpeutics?
Magenta Therpeutics's investors include Casdin Capital, Third Rock Ventures, Access Industries, Partners HealthCare Innovation and Be The Match BioTherapies, and 1 more on record.
United States · Series B startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2017, from 1 source
Magenta Therpeutics's investors include Casdin Capital, Third Rock Ventures, Access Industries, Partners HealthCare Innovation and Be The Match BioTherapies, and 1 more on record.
Magenta Therpeutics has raised $50M across 1 round since 2017.
Magenta Therpeutics's most recent round was a Series B of $50M in May 2017.
Its most recent round, $50M in May 2017, is also its largest on record.
Magenta Therpeutics's first round on record, in May 2017, was backed by Casdin Capital, Third Rock Ventures and Access Industries and 3 others.
Magenta Therpeutics's latest named round is a Series B, in May 2017.
Magenta Therpeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.